Large-scale testing (Phase 3)WithdrawnNCT06482359What this trial is testingLot Consistency Study of COVID-19 and Influenza Combination VaccineWho this might be right forCOVID-19Influenza Novavax
Large-scale testing (Phase 3)Study completedNCT00333398What this trial is testingImmunogenicity, Safety and Tolerability of CSL Limited Inactivated Influenza Vaccine in AdultsWho this might be right forInfluenza National Institute of Allergy and Infectious Diseases (NIAID) 1,359
Not applicableActive Not RecruitingNCT04671693What this trial is testingA Post-treatment Program to Identify and Manage Complications Related to Oncology or Hematology Treatments in Cancer Survivors.Who this might be right forLate EffectsTesticular Germ Cell Tumor MixedNon-Metastatic Breast Carcinoma+6 more Centre Leon Berard 500
Testing effectiveness (Phase 2)Study completedNCT04789577What this trial is testingEvaluate the Safety and Immunogenicity of GlaxoSmithKline Biologicals' Influenza Vaccine GSK3206641A Administered in Adults 18 to 64 Years of Age and 65 Years of Age and OlderWho this might be right forInfluenza, Human GlaxoSmithKline 833
Early research (Phase 1)Ended earlyNCT05420077What this trial is testingSafety and Immunogenicity of RVM-V001 in Healthy Individuals Previously Vaccinated With BNT162b2 and mRNA-1273Who this might be right forInfectious DiseaseCOVID-19 RVAC Medicines (US), Inc. 13
Not applicableEnrolling By InvitationNCT07242326What this trial is testingSNAP AF-52: Dose Appropriateness and Adherence to Oral Anticoagulation in Adults ≥65 With Atrial Fibrillation in Primary Care (Ordu, Türkiye)Who this might be right forMedication AdherenceAtrial Fibrillation (AF)Direct Oral Anticoagulants (DOACs) Kotyora Family Medicine Health Management and Education Association 1,000
Testing effectiveness (Phase 2)Study completedNCT00706732What this trial is testingA Safety and Immunogenicity Trial in Adults 65 Years of Age or Over to Prevent InfluenzaWho this might be right forInfluenza AlphaVax, Inc. 28
Not applicableUnknownNCT05941650What this trial is testingTo Study the Effect of Short-chain Fructooligosaccharides in Women With Irritable Bowel SyndromeWho this might be right forIrritable Bowel SyndromeDiarrhea- Irritable Bowel SyndromeConstipation-predominant Irritable Bowel Syndrome Universidad Autonoma de Chihuahua 40
Testing effectiveness (Phase 2)Study completedNCT04969276What this trial is testingStudy of a Quadrivalent High-Dose Influenza Vaccine and a Moderna COVID-19 Vaccine Administered Either Concomitantly or Singly in Participants 65 Years of Age and Older Previously Vaccinated With a 2-dose Schedule of Moderna COVID-19 VaccineWho this might be right forInfluenza ImmunizationHealthy Volunteers Sanofi Pasteur, a Sanofi Company 306
Not applicableStudy completedNCT01668836What this trial is testingInfluence of Caloric Restriction and Resveratrol in the Sirtuin System in Women and Men Aged 55 to 65 YearsWho this might be right forVascular System InjuriesLipid Metabolism DisordersEndothelial Disfunction InCor Heart Institute 48
Testing effectiveness (Phase 2)Study completedNCT04622592What this trial is testingAdjuvanted Seasonal Recombinant Quadrivalent Virus-Like Particles (QVLP) Influenza Vaccine in Adults 65 Years of Age and OlderWho this might be right forInfluenza Medicago 209
Testing effectiveness (Phase 2)Ended earlyNCT03982199What this trial is testingAn Ad26.RSV.preF-based Regimen in the Prevention of Reverse Transcriptase Polymerase Chain Reaction (RT-PCR)-Confirmed Respiratory Syncytial Virus (RSV)-Mediated Lower Respiratory Tract Disease in Adults Aged 65 Years and OlderWho this might be right forRespiratory Syncytial VirusesRespiratory Tract Diseases Janssen Vaccines & Prevention B.V. 5,815
Early research (Phase 1)Study completedNCT00848848What this trial is testingSafety, Tolerability, and Immunogenicity of Different Combinations of Trivalent Influenza Vaccine Varying Influenza Antigen Dose, Adjuvant Dose, and Route of Administration in Healthy Elderly Individuals Ages 65 Years and OlderWho this might be right forInfluenza Seqirus 450
Not applicableStudy completedNCT03155217What this trial is testingTolerance of Targeted Therapy Used in Metastatic Melanoma in Patients Aged Over 65 and 75-year-oldWho this might be right forMetastatic Melanoma University Hospital, Montpellier 358
Not applicableNot Yet RecruitingNCT07043933What this trial is testingEffect of a Mobile-Based Hydration Tracking Program on Knowledge, Attitudes, and Behaviors in Older AdultsWho this might be right forDehydrationOlder Adults (65 Years and Older)Hydration Status+3 more Ezgi Atasoy 70
Testing effectiveness (Phase 2)Ended earlyNCT01627314What this trial is testingThe PUMA Trial is a Trial of a Single ProHema Modulated-Cord Blood (CB) Unit as Part of a Double CB Transplant in Patients With Hematologic Malignancies.Who this might be right forHematologic Malignancies Fate Therapeutics 62
Large-scale testing (Phase 3)Study completedNCT00002720What this trial is testingSurgery With or Without Lymph Node Removal in Treating Older Women With Stage I Breast CancerWho this might be right forBreast Cancer European Institute of Oncology 642
Testing effectiveness (Phase 2)Study completedNCT01224262What this trial is testingA Study Evaluating the Safety and Tolerability of a Seasonal Influenza Vaccine Containing LIQ001Who this might be right forInfluenza Liquidia Technologies, Inc. 152
Early research (Phase 1)Study completedNCT00318058What this trial is testingSafety Study of an Adjuvanted Candidate Influenza Vaccine to Prevent Influenza Disease in the Elderly PopulationWho this might be right forInfluenza GlaxoSmithKline 84
Large-scale testing (Phase 3)Looking for participantsNCT06247085What this trial is testingInvestigate Efficacy and Safety of Pegtibatinase Compared With Placebo in Participants ≥12 to ≤65 Years of Age With Classical Homocystinuria (HCU) Due to Cystathionine Beta Synthase Deficiency Receiving Standard of Care TreatmentWho this might be right forHomocystinuria Travere Therapeutics, Inc. 70